Your question concerning the interest expressed by Canada's generic drug industry is excellent. Only two of the 30 submissions received in response to our consultation paper were from generic drug companies. I think that speaks volumes about the situation.
As for other incentives, that's really not my area of expertise. I know that some measures are already in place. The government recently announced similar measures, but I'm not familiar with the details. A number of innovative companies do take advantage of this type of tax credit to supply various pharmaceutical products to developing countries.